Atlas Trials

A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )

Clinical trial NCT00002156 · COMPLETED

Trial details

NCT number
NCT00002156
Sponsor
Ionis Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cytomegalovirus RetinitisHIV Infections
Enrollment
194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.